12:05 , Jun 22, 2018 |  BioCentury  |  Finance

Regenerating eastward

Having capitalized on the cell therapy expertise and manufacturing incentives of its European home base, Promethera Biosciences S.A. is expanding to Japan to tap the commitment to regenerative medicines among investors, pharmas and regulators. After...
07:00 , Apr 27, 2015 |  BC Week In Review  |  Financial News

Cell Innovation Partners L.P. financial update

Cell Innovation Partners L.P. , Cayman Islands   Business: Finance   Date announced: 2015-04-20   Note: ReproCell Inc. (JASDAQ:4978, Yokohama, Japan) and Shinsei Bank, a subsidiary of Shinsei Corporate Investment Ltd., closed its Cell Innovation...
07:00 , Oct 6, 2014 |  BC Week In Review  |  Financial News

Cell Innovation Partners L.P. financial update

ReproCell markets induced pluripotent stem cell (iPSC)-derived cardiomyocytes, neurons and hepatocytes for drug discovery. The company also markets primary cells for diabetes research and media and reagents for embryonic stem cells and iPSCs. Cell Innovation...